Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GLAUKOS Corp Director's Dealing 2024

Mar 18, 2024

31074_dirs_2024-03-18_d3782337-0c2b-4033-8336-13daf261e088.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GLAUKOS Corp (GKOS)
CIK: 0001192448
Period of Report: 2024-03-14

Reporting Person: Burns Thomas William (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-03-14 Common Stock A 2084 Acquired 57522 Direct
2024-03-14 Common Stock A 15418 Acquired 72940 Direct
2024-03-14 Common Stock A 21275 Acquired 94215 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-14 Stock Option (Right to Buy) $55.18 A 4208 Acquired 2032-03-24 Common Stock (4208) Direct
2024-03-14 Stock Option (Right to Buy) $49.51 A 56404 Acquired 2033-04-03 Common Stock (56404) Direct
2024-03-14 Stock Option (Right to Buy) $85.78 A 36891 Acquired 2034-03-14 Common Stock (36891) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 893932 Indirect
Common Stock 238107 Indirect
Common Stock 120000 Indirect
Common Stock 100000 Indirect
Common Stock 100000 Indirect

Footnotes

F1: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 24, 2022, the earning and vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 14, 2024 that certain of the operational targets had been achieved. The number of shares of common stock reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. 50% of the number of shares of common stock reported herein will vest and be delivered in March 2024, and the remaining 50% will vest and be delivered in December 2024.

F2: Includes 48,462 restricted stock units that have not yet vested or been delivered to the Reporting Person.

F3: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 18, 2021, the earning and vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on March 14, 2024 that one of the operational targets had been achieved. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement of the operational target. 50% of the number of shares of common stock reported herein will vest and be delivered in March 2024 and the remaining 50% will vest and be delivered in December 2024.

F4: Includes 63,880 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person.

F5: Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date.

F6: Includes 85,155 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person.

F7: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on March 14, 2024 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.

F8: 50% of the portion of the option reported herein will vest and become exercisable in March 2024, and the remaining 50% will vest and become exercisable in December 2024.

F9: Represents an option to purchase shares of common stock previously granted by the Issuer on April 3, 2023 pursuant to the Reporting Person's election to receive his annual bonus for 2023 in the form of stock options rather than cash (the "Bonus Election"). The Issuer's Board of Directors determined on March 14, 2024 the annual bonus payable to the Reporting Person pursuant to the Issuer's 2023 executive bonus plan and the number of shares of common stock subject to the stock option earned by the Reporting Person in accordance with the Bonus Election, subject to continued employment through the vesting date.

F10: The option to purchase common stock will vest on April 1, 2024.

F11: This option was granted on March 14, 2024 and has a four-year vesting schedule in which 25% vests on the first anniversary of the grant date and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date.